Man Xu Selected Research

azvudine

5/2024	Adherence and recommended optimal treatment to Azvudine application for the treatment of outpatient COVID-19 patients: A real-world retrospective study.
1/2023	Oral azvudine for mild-to-moderate COVID-19 in high risk, nonhospitalized adults: Results of a real-world study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Man Xu Research Topics

Disease

44	Neoplasms (Cancer) 04/2024 - 06/2002
14	Cardiomegaly (Heart Hypertrophy) 05/2024 - 05/2015
12	Fibrosis (Cirrhosis) 05/2024 - 10/2003
11	Infections 09/2023 - 01/2014
11	Inflammation (Inflammations) 12/2022 - 11/2015
9	Hypertrophy 01/2023 - 05/2015
9	Nasopharyngeal Carcinoma 01/2021 - 01/2012
8	Neuroblastoma 04/2024 - 04/2012
7	Syphilis 12/2022 - 02/2016
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 09/2012
6	Hypoxia (Hypoxemia) 01/2019 - 06/2013
6	Lymphatic Metastasis 01/2019 - 01/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 08/2016
5	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2019
5	Papillary Thyroid Cancer 01/2019 - 01/2014
4	COVID-19 05/2024 - 10/2020
4	Hypertension (High Blood Pressure) 05/2024 - 08/2016
4	Disease Progression 05/2024 - 10/2022
4	Carcinogenesis 03/2024 - 04/2010
4	Heart Failure 01/2023 - 01/2019
4	Atherosclerosis 12/2022 - 10/2016
4	Hyperplasia 01/2017 - 01/2013
3	Wounds and Injuries (Trauma) 10/2023 - 01/2018
3	Sleep Wake Disorders 01/2023 - 12/2003
3	Keratoconus 01/2023 - 06/2019
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2022 - 11/2019
3	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2010
3	Squamous Cell Carcinoma of Head and Neck 01/2020 - 01/2013
3	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 10/2018
3	Neoplasm Metastasis (Metastasis) 01/2020 - 05/2016
3	Carcinoma (Carcinomatosis) 01/2018 - 01/2015
3	Ischemia 04/2015 - 10/2009
2	Autism Spectrum Disorder 07/2024 - 01/2023
2	Birth Weight (Birth Weights) 04/2024 - 03/2017
2	Diabetes Mellitus 01/2024 - 01/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2023 - 10/2003
2	Autistic Disorder (Autism) 01/2023 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2018
2	Ventricular Remodeling 12/2022 - 01/2020
2	Anemia 11/2022 - 01/2012
2	Blast Crisis (Blast Phase) 10/2022 - 11/2019
2	Adenoma (Adenomas) 01/2022 - 01/2015
2	Ureteral Obstruction 11/2021 - 01/2018
2	Chronic Renal Insufficiency 11/2021 - 01/2020
2	Glioma (Gliomas) 01/2021 - 07/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 09/2019
2	Colonic Neoplasms (Colon Cancer) 09/2020 - 05/2020
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2020 - 12/2014

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2010
9	Messenger RNA (mRNA)IBA 01/2023 - 04/2010
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2012
7	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2020
7	CytokinesIBA 12/2022 - 01/2014
6	Angiotensin IIIBA 05/2024 - 05/2015
6	Tyrosine Kinase InhibitorsIBA 04/2024 - 01/2019
6	VaccinesIBA 01/2023 - 10/2010
6	AntigensIBA 01/2021 - 11/2012
5	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2017 - 04/2015
4	Transcription Factors (Transcription Factor)IBA 04/2024 - 01/2021
4	ErbB Receptors (EGF Receptor)IBA 04/2024 - 01/2020
4	Choline (Choline Chloride)IBA 12/2022 - 12/2015
4	Interleukin-6 (Interleukin 6)IBA 12/2022 - 01/2018
4	LipidsIBA 11/2022 - 04/2019
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 10/2018
4	Cisplatin (Platino)FDA LinkGeneric 09/2020 - 09/2012
4	Immunoglobulin M (IgM)IBA 09/2019 - 02/2016
3	RNA (Ribonucleic Acid)IBA 01/2023 - 09/2019
3	Aurora Kinase AIBA 01/2023 - 01/2020
3	Long Noncoding RNAIBA 06/2022 - 01/2021
3	Phosphotransferases (Kinase)IBA 01/2022 - 05/2015
3	EpitopesIBA 01/2019 - 01/2010
3	AntibodiesIBA 11/2018 - 01/2010
3	FlagellinIBA 01/2018 - 02/2016
2	MelatoninIBA 07/2024 - 01/2023
2	Mitochondrial DNA (mtDNA)IBA 05/2024 - 01/2018
2	azvudineIBA 05/2024 - 01/2023
2	Histone ChaperonesIBA 05/2024 - 10/2022
2	ChromatinIBA 05/2024 - 10/2019
2	MetalsIBA 01/2024 - 02/2021
2	SolutionsIBA 07/2023 - 04/2015
2	Blood Glucose (Blood Sugar)IBA 06/2023 - 10/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 09/2020
2	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 05/2020
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 01/2019
2	TriterpenesIBA 08/2022 - 01/2018
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 08/2022 - 01/2022
2	AntioxidantsIBA 01/2022 - 07/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2015
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 01/2020
2	Bevacizumab (Avastin)FDA Link 01/2021 - 07/2020
2	Small Interfering RNA (siRNA)IBA 01/2021 - 10/2019
2	AcidsIBA 09/2020 - 08/2019
2	Docetaxel (Taxotere)FDA Link 09/2020 - 09/2012

Therapy/Procedure

19	Therapeutics 01/2022 - 08/2007
7	Radiotherapy 05/2016 - 08/2011
5	Drug Therapy (Chemotherapy) 04/2015 - 08/2011
4	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021 - 01/2012
4	Induction Chemotherapy 09/2020 - 01/2017
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2018 - 06/2002
2	Corneal Cross-Linking 11/2020 - 06/2019